D Imbs

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients

François Bécher, Joseph Ciccolini, D Imbs et al. · Scientific Reports · 2017 · 54 citations · Full text

Improved stability of lipiodol–drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin

Mathieu Boulin, Antonin Schmitt, E. Delhom et al. · European Radiology · 2015 · 42 citations

Pharmaceutical Science, Drug Targeting, Transarterial Chemoembolisation +9

CDA as a predictive marker for life-threatening toxicities in patients with AML treated with cytarabine

Raphaëlle Fanciullino, Laure Farnault, Mélanie Donnette et al. · Blood Advances · 2018 · 41 citations · Full text

Inhibition of OCT2, MATE1 and MATE2-K as a possible mechanism of drug interaction between pazopanib and cisplatin

Chloé Sauzay, Mélanie White‐Koning, Isabelle Hennebelle et al. · Pharmacological Research · 2016 · 39 citations

Chromatin, Drug Interaction, Medicine +8

Model driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis

Séverine Mollard, Joseph Ciccolini, D Imbs et al. · Oncotarget · 2017 · 37 citations · Full text

Immunology, Tumor Biology, Model Driven Optimization +16